Federal Compliance Solutions, an IntegriChain Company

We are excited to announce that we are joining with IntegriChain! Our domain knowledge and quality IntegriChain’s data and tech innovation = the leading net revenue management outsourcing and consulting capability for the Pharma industry. We’re excited to join forces and to optimize pricing, contracting, and GTN for more profitable business decisioning while accelerating innovation! Read more: https://bit.ly/4eSQOIp

✨CMS Guidance on ASP Restatements CMS has issued updated guidelines for correcting Average Sales Price (ASP) data for Medicare Part B drugs and biologicals. This new guidance aims to enhance the accuracy and transparency of ASP data and payment limits. Stay informed on these crucial updates to ensure compliance and accurate reporting. For more details, read our latest blog. Richard Moore Jim Flowers #FCSinsights #pharma #pharmanews

Good news and a win for Pharma and Biotech! CMS released a statement that Best Price stacking will not be in this Final Rule (see below for the full press release). This was a bad proposal and would have been a nightmare to implement (cheers to the life science industry on this win!). Note we are still waiting on the final rule from CMS. Stay tuned for more details. https://lnkd.in/enUjSF7M #GovernmentPricing #MDRP #BestPrice #LifeSciences

✨Decoding Gross-to-Net: Essential Process Design Considerations   Gross-to-Net process management is an increasingly complex undertaking for Life Sciences organizations. Manufacturers have dynamic structures and stakeholders, unique pricing and contracting dynamics, and are required to manage forecasts and accruals in a rapidly changing regulatory environment. The first in a series of three White Papers, our latest blog post offers key insights and instructions for managing the intricacies of Gross-to-Net. Read the full article for an in-depth look at Gross-to-Net process design, and follow our series to improve your organization's revenue management! #FCSinsights #pharma #grosstonet Walter Worsham Henry lin, CFA; Galina Beers, MBA Shree Mukesh Kumar Vutla

✨ Navigating Pharma Regulatory Changes for 2024 The regulatory landscape for drug manufacturers is shifting, with new and revised guidance impacting participation in key government programs like the 340B Drug Pricing Program, Medicaid Drug Rebate Program, Medicare Part B and D, and more. Our latest blog post offers a comprehensive summary of these changes and explores the implications for manufacturers. Read the full article for a deep dive into the latest developments and how they might impact your organization 💡 #FCSinsights #pharma #drugpricing Richard Moore Jeff Blake Nicholas Lynch, CFE Jake Keenan Jim Flowers

Samruddhi Londhe has joined FCS as an Analyst and will be primarily focusing on supporting our Managed Care operations and related services! We are thrilled to have her. Please join us in welcoming Sam to the team 👏 and see below to learn more about her.

Pallavi Kshirsagar has joined FCS as an Analyst and will be supporting our Managed Services offering! We are thrilled to have her. Please join us in welcoming Pallavi to the team 👏 and see below to learn more about her.

We are excited to share that FCS will be a part of Propel Launch Summit 🚀, an immersive learning experience focused on launching products in oncology, rare disease, and cell and gene therapy. This intimate, unique event was created specifically for CEOs, CCOs, and other leaders of commercialization or market access teams involved in launches. Propel Launch Summit is happening May 20-22, 2024 in Indianapolis. Don’t miss your chance to: - Identify your launch blind spots - Have 1:1 time with industry leaders and peers - Get insight into market dynamics, payer intelligence, and trends - Walk away with a game plan for launch success Propel Launch Summit is fueled by longtime leaders in biopharma market access, DKP. They know firsthand how mission-critical it is to get your launch right the first time. That’s why they’re hosting this power-packed, curated experience focused on ensuring robust launches. Tickets are limited, so register today! We hope to see you there. propellaunch.com #propellaunch #propellaunchsummit

🚀 Exciting news reminder! One of our Government Pricing experts, Jim Flowers, will be presenting tomorrow, March 19th, 2024, at the 22nd Annual Rx Drug Pricing Conference on 'Rx Drug Pricing & Rebate Fundamentals'. 💼 The workshop will be an intensive training focused on essential pricing and rebate concepts, methodologies, and strategies for key government payor programs. Don't miss out! Check out more details here https://lnkd.in/edje-KKx 🏷️ You can also save 10% by using the code: S10-124-124L24.S

Lori Locker Corvin has joined FCS as an Operations Manager and will be focusing on our Managed Services Rebate Operations! We are thrilled to have her. Please join us in welcoming Lori to the team 👏 and see below to learn more about her. #FCSisgrowing #lifesciences #pharma #managedservices